A patient with CKD and an atypical bone fracture after long-term use of bisphosphonates
ERBP
9 / 9 results found
SGLT2i for evidence based cardiorenal protection in diabetic and non-diabetic chronic kidney disease
Speaker
Patrick Mark, United Kingdom
Panellists
Evangelia Dounousi, Greece
Sokratis Stoumpos, United Kingdom
Moderator
Pantelis Sarafidis, Greece
ERBP